BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32768677)

  • 1. Sodium current abnormalities and deregulation of Wnt/β-catenin signaling in iPSC-derived cardiomyocytes generated from patient with arrhythmogenic cardiomyopathy harboring compound genetic variants in plakophilin 2 gene.
    Khudiakov A; Zaytseva A; Perepelina K; Smolina N; Pervunina T; Vasichkina E; Karpushev A; Tomilin A; Malashicheva A; Kostareva A
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165915. PubMed ID: 32768677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [THE EFFECT OF PLAKOPHILIN-2 GENE MUTATIONS ON ACTIVITY OF THE CANONICAL Wnt SIGNALING PATHWAY].
    Khudiakov AA; Kostina DA; Kostareva AA; Tomilin AN; Malashicheva AB
    Tsitologiia; 2015; 57(12):868-75. PubMed ID: 26995964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype.
    Cerrone M; Lin X; Zhang M; Agullo-Pascual E; Pfenniger A; Chkourko Gusky H; Novelli V; Kim C; Tirasawadichai T; Judge DP; Rothenberg E; Chen HS; Napolitano C; Priori SG; Delmar M
    Circulation; 2014 Mar; 129(10):1092-103. PubMed ID: 24352520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatiotemporal cell junction assembly in human iPSC-CM models of arrhythmogenic cardiomyopathy.
    Kim SL; Trembley MA; Lee KY; Choi S; MacQueen LA; Zimmerman JF; de Wit LHC; Shani K; Henze DE; Drennan DJ; Saifee SA; Loh LJ; Liu X; Parker KK; Pu WT
    Stem Cell Reports; 2023 Sep; 18(9):1811-1826. PubMed ID: 37595583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes.
    Inoue H; Nakamura S; Higo S; Shiba M; Kohama Y; Kondo T; Kameda S; Tabata T; Okuno S; Ikeda Y; Li J; Liu L; Yamazaki S; Takeda M; Ito E; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
    Stem Cell Reports; 2022 Feb; 17(2):337-351. PubMed ID: 35063130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
    Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
    Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
    Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
    Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of two edited iPSCs lines by CRISPR/Cas9 with point mutations in PKP2 gene for arrhythmogenic cardiomyopathy in vitro modeling.
    Amin G; Castañeda SL; Zabalegui F; Belli C; Atorrasagasti C; Miriuka SG; Moro LN
    Stem Cell Res; 2023 Sep; 71():103157. PubMed ID: 37393721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of iPSC line from patient with arrhythmogenic right ventricular cardiomyopathy carrying mutations in PKP2 gene.
    Khudiakov A; Kostina D; Zlotina A; Yany N; Sergushichev A; Pervunina T; Tomilin A; Kostareva A; Malashicheva A
    Stem Cell Res; 2017 Oct; 24():85-88. PubMed ID: 29034900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-specific iPSC-derived cardiomyocytes reveal aberrant activation of Wnt/β-catenin signaling in SCN5A-related Brugada syndrome.
    Cai D; Wang X; Sun Y; Fan H; Zhou J; Yang Z; Qiu H; Wang J; Su J; Gong T; Jiang C; Liang P
    Stem Cell Res Ther; 2023 Sep; 14(1):241. PubMed ID: 37679791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmosomal protein degradation as an underlying cause of arrhythmogenic cardiomyopathy.
    Tsui H; van Kampen SJ; Han SJ; Meraviglia V; van Ham WB; Casini S; van der Kraak P; Vink A; Yin X; Mayr M; Bossu A; Marchal GA; Monshouwer-Kloots J; Eding J; Versteeg D; de Ruiter H; Bezstarosti K; Groeneweg J; Klaasen SJ; van Laake LW; Demmers JAA; Kops GJPL; Mummery CL; van Veen TAB; Remme CA; Bellin M; van Rooij E
    Sci Transl Med; 2023 Mar; 15(688):eadd4248. PubMed ID: 36947592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.
    Kim C; Wong J; Wen J; Wang S; Wang C; Spiering S; Kan NG; Forcales S; Puri PL; Leone TC; Marine JE; Calkins H; Kelly DP; Judge DP; Chen HS
    Nature; 2013 Feb; 494(7435):105-10. PubMed ID: 23354045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Truncating plakophilin-2 mutations in arrhythmogenic cardiomyopathy are associated with protein haploinsufficiency in both myocardium and epidermis.
    Rasmussen TB; Nissen PH; Palmfeldt J; Gehmlich K; Dalager S; Jensen UB; Kim WY; Heickendorff L; Mølgaard H; Jensen HK; Baandrup UT; Bross P; Mogensen J
    Circ Cardiovasc Genet; 2014 Jun; 7(3):230-40. PubMed ID: 24704780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9-edited PKP2 knock-out (JMUi001-A-2) and DSG2 knock-out (JMUi001-A-3) iPSC lines as an isogenic human model system for arrhythmogenic cardiomyopathy (ACM).
    Janz A; Zink M; Cirnu A; Hartleb A; Albrecht C; Rost S; Klopocki E; Günther K; Edenhofer F; Ergün S; Gerull B
    Stem Cell Res; 2021 May; 53():102256. PubMed ID: 33640690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel murine model for arrhythmogenic cardiomyopathy points to a pathogenic role of Wnt signalling and miRNA dysregulation.
    Calore M; Lorenzon A; Vitiello L; Poloni G; Khan MAF; Beffagna G; Dazzo E; Sacchetto C; Polishchuk R; Sabatelli P; Doliana R; Carnevale D; Lembo G; Bonaldo P; De Windt L; Braghetta P; Rampazzo A
    Cardiovasc Res; 2019 Mar; 115(4):739-751. PubMed ID: 30304392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the Role of Wnt and Rho Signaling Pathway in iPSC-Derived ARVC Cardiomyocytes by In Silico Mathematical Modeling.
    Parrotta EI; Procopio A; Scalise S; Esposito C; Nicoletta G; Santamaria G; De Angelis MT; Dorn T; Moretti A; Laugwitz KL; Montefusco F; Cosentino C; Cuda G
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivation of human induced pluripotent stem cell line EURACi004-A from skin fibroblasts of a patient with Arrhythmogenic Cardiomyopathy carrying the heterozygous PKP2 mutation c.2569_3018del50.
    Ermon B; Volpato CB; Cattelan G; Silipigni R; Di Segni M; Cantaloni C; Casella M; Pramstaller PP; Pompilio G; Sommariva E; Meraviglia V; Rossini A
    Stem Cell Res; 2018 Oct; 32():78-82. PubMed ID: 30219716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human PKP2/plakophilin-2 gene is induced by Wnt/β-catenin in normal and colon cancer-associated fibroblasts.
    Niell N; Larriba MJ; Ferrer-Mayorga G; Sánchez-Pérez I; Cantero R; Real FX; Del Peso L; Muñoz A; González-Sancho JM
    Int J Cancer; 2018 Feb; 142(4):792-804. PubMed ID: 29044515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of arrhythmogenic right ventricular cardiomyopathy: emerging horizon?
    van Tintelen JP; Hofstra RM; Wiesfeld AC; van den Berg MP; Hauer RN; Jongbloed JD
    Curr Opin Cardiol; 2007 May; 22(3):185-92. PubMed ID: 17413274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Wnt/β-catenin signaling upregulates Na
    Lu A; Gu R; Chu C; Xia Y; Wang J; Davis DR; Liang W
    Physiol Rep; 2023 May; 11(10):e15696. PubMed ID: 37226398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.